Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Others), and Region 2023-2028
The global transcriptomics market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.54 Billion by 2028, exhibiting a growth rate (CAGR) of 6.60% during 2023-2028.
Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.
Transcriptomics Market Trends:
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, application and end user.
Breakup by Type:
Instruments
Consumables
Software
Services
Breakup by Technology:
Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
Breakup by Application:
Diagnostics and Disease Profiling
Drug Discovery
Others
Breakup by End User:
Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global transcriptomics market in 2022?
2. What is the expected growth rate of the global transcriptomics market during 2023-2028?
3. What are the key factors driving the global transcriptomics market?
4. What has been the impact of COVID-19 on the global transcriptomics market?
5. What is the breakup of the global transcriptomics market based on type?
6. What is the breakup of the global transcriptomics market based on the technology?
7. What is the breakup of the global transcriptomics market based on the application?
8. What are the key regions in the global transcriptomics market?
9. Who are the key players/companies in the global transcriptomics market?
Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.
Transcriptomics Market Trends:
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, application and end user.
Breakup by Type:
Instruments
Consumables
Software
Services
Breakup by Technology:
Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
Breakup by Application:
Diagnostics and Disease Profiling
Drug Discovery
Others
Breakup by End User:
Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global transcriptomics market in 2022?
2. What is the expected growth rate of the global transcriptomics market during 2023-2028?
3. What are the key factors driving the global transcriptomics market?
4. What has been the impact of COVID-19 on the global transcriptomics market?
5. What is the breakup of the global transcriptomics market based on type?
6. What is the breakup of the global transcriptomics market based on the technology?
7. What is the breakup of the global transcriptomics market based on the application?
8. What are the key regions in the global transcriptomics market?
9. Who are the key players/companies in the global transcriptomics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TRANSCRIPTOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Microarray
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sequencing Technologies
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Diagnostics and Disease Profiling
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Discovery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic and Research Institutes
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharmaceutical Companies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BGI Group
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Bio-Rad Laboratories Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Biospyder Technologies Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Illumina Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Nanostring Technologies Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Qiagen
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Roche Holding AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Takara Bio Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL TRANSCRIPTOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Microarray
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sequencing Technologies
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Diagnostics and Disease Profiling
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Discovery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic and Research Institutes
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharmaceutical Companies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BGI Group
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Bio-Rad Laboratories Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Biospyder Technologies Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Illumina Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Nanostring Technologies Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Qiagen
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Roche Holding AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Takara Bio Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
LIST OF TABLES
Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Transcriptomics Market: Competitive Structure
Table 8: Global: Transcriptomics Market: Key Players
Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Transcriptomics Market: Competitive Structure
Table 8: Global: Transcriptomics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2022
Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2022
Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2022
Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2022
Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Transcriptomics Industry: SWOT Analysis
Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis
Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2022
Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2022
Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2022
Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2022
Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Transcriptomics Industry: SWOT Analysis
Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis
